Medtide HK$411.2 million IPO
We advised Medtide on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Mirxes Holding Company HK$1.09 billion IPO
We advised Mirxes on its IPO and HKEX listing
ADC Therapeutics $100 million private placement
We advised ADC Therapeutics on the equity offering
Omada Health $172.6 million IPO
The shares are listed on the Nasdaq Global Select Market
PegBio IPO
We advised PegBio on its IPO and HKEX listing
Hinge Health $503 million IPO
The shares are listed on the New York Stock Exchange
Kenvue $750 million senior notes offering
The investment-grade notes are due 2032
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Auna $62.1 million senior secured notes offering
We advised Auna on the offering